Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration

Denosumab is a human monoclonal antibody indicated for the treatment of osteoporosis in postmenopausal women with a high risk of fractures. To our knowledge, no cases of desensitization to this drug have been described in the literature. We report the first case of generalized urticarial reaction an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Allergy Asthma Clin Immunol
Main Authors: Gutiérrez-Fernández, D., Cruz, María-Jesús, Foncubierta-Fernández, A., Moreno-Ancillo, A., Fernández-Anguita, M. J., Medina-Varo, F., Andres-García, J. A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4620716/
https://ncbi.nlm.nih.gov/pubmed/26504466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-015-0097-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki